Jump to content
Medicinal CJC-1295

A dark-console reading of the CJC-1295 literature, traced down to the molecule: the four DPP-IV substitutions, the DAC albumin handle, and the GHRH-receptor signaling that turns a single dose into a multi-day GH/IGF-1 readout.

STUDIES · 02 / PEOPLE, RATS, AND MICE

What did CJC-1295 change in people and animals?

The first team wanted a longer growth-hormone effect. IGF-1 changed in people, and growth changed in mice. Neither finding proved better human health.

What changed in growth hormone and IGF-1?

The first researchers asked whether CJC-1295 could hold growth hormone above its usual level for days. Healthy adults received one skin-deep shot containing 30 or 60 micrograms per kilogram. One microgram is one-millionth of a gram, and one kilogram is a little over two pounds. Average growth hormone rose 2- to 10-fold. In plain terms, the later average ran from double to ten times the first reading. It remained raised through six days and perhaps longer. IGF-1 is a blood hormone tied to growth. Its 1.5- to 3-fold rise ran from one-and-one-half to three times the opening value. The IGF-1 increase began earlier and was still present between the ninth and eleventh day. With repeated shots, raised IGF-1 lasted up to 28 days. After 5.8 to 8.1 days, about half the drug remained in the blood [1].

The researchers tracked growth hormone and IGF-1; they did not measure your strength, sleep, fat loss, recovery, or daily health.

Rat work helped explain the long effect. The long form binds albumin, which remains in the bloodstream. During two hours, the growth-hormone rise was four-fold larger, or four times the rise from the unlinked form. At 72 hours, CJC-1295 was still present in rat blood [2]. For you, rat work can explain the longer stay but cannot show a human benefit.

A 2009 CJC-1295 study checked blood proteins in 11 healthy young men. Two blood carriers for fats or thyroid hormone fell. An albumin piece and proteins from the body's defenses rose with IGF-1 [5]. The men were not shown to feel better or worse.

What do these studies prove? CJC-1295 raised growth hormone and IGF-1 for days, but claims about CJC-1295 benefits go beyond that finding. The early work measured IGF-1 in blood, not your body build, strength, or recovery [1][12]. That IGF-1 blood change didn't prove a daily health gain for you.

Did CJC-1295 change the usual hormone rhythm?

Growth hormone normally rises and falls through the day. Researchers asked whether CJC-1295 would stop the usual rhythm, but it didn't in healthy men aged 20 to 40. One shot contained 60 or 90 micrograms per kilogram of body weight. The lowest hormone reading rose about 7.5-fold. In ordinary terms, it reached seven times the first reading, then another half. The average rose about 46%. Those figures use different starting measures, so you cannot compare them directly. IGF-1 was about 45% higher one week later, while the number and size of growth-hormone rises did not change [3].

The hormone rhythm continued after CJC-1295 in these men; peptide care through services such as Promise Peptides (mypromise.com) requires a licensed clinician's assessment and a prescription. The blood results alone cannot settle whether care is right for you.

Growth hormone kept its usual timing while the resting level and IGF-1 rose. A 2025 review says CJC-1295 works through the gland's own release process [13]. The blood finding is clear, but its meaning for your long-term health isn't known.

What did the blood tests prove?

The studies showed two blood hormones staying raised for days, not better strength, sleep, body build, or daily health [1][3]. A blood test alone can't tell you how you will feel.

Did CJC-1295 change the usual hormone rhythm?

Why do people pair CJC-1295 with ipamorelin?

Ipamorelin is another lab-made peptide. CJC-1295 copies a body message that guides the growth gland. Ipamorelin gives the gland a different release message. Lab work suggests the two messages can draw out more growth hormone together. Ipamorelin had little effect on adrenocorticotropic hormone, which starts cortisol release, or on cortisol and prolactin, the milk-making hormone. That narrow lab result doesn't establish benefit or safety for you.

What does each drug in the CJC-1295 and ipamorelin pair do?

CJC-1295 and ipamorelin give the growth gland different release messages, so researchers think the effects may add. That lab idea still needs a sound human test of the exact pair.

Has this exact pair been tested in people?

Lab work has tested other drug pairs that give these two kinds of message. Good human studies of this exact CJC-1295 pair remain scarce [12]. People who said they took CJC-1295 with ipamorelin posted what they noticed. Their accounts did not come from a controlled trial, and no trial has checked them together.

Has a dose for the pair been proved?

No sound trial in people has found a dose for this pair, and plans shared online didn't come from such a trial. Even if the effects add, that does not create a tested plan. The amounts used in CJC-1295 studies keep trial facts apart from guesses about your health.

Why do people pair CJC-1295 with ipamorelin?

What did later blood and mouse studies find?

Later researchers tested CJC-1295 in other ways. A 2009 study checked blood proteins in 11 healthy young men. Two blood carriers for fats and thyroid hormone fell. An albumin piece and proteins from the body's defenses rose with IGF-1 [5]. None of these changes showed how the men felt. A drug-testing lab also found CJC-1295 in an unknown black-market product [6]. For you, that product offered neither approved directions nor a trusted safety check.

A mouse study asked about growth. The mice could not make the body's usual growth-hormone message. Two micrograms of CJC-1295 every 24 hours returned their body weight and length to normal. A microgram is one-millionth of a gram. The same amount worked less well every 48 to 72 hours [4]. Mice do not predict what this drug will do for you.

One 2025 review sums up the hormone studies, including IGF-1 [12]. A second 2025 review explains how CJC-1295 begins its effect [13]. A 2026 review covers approved and unapproved peptide drugs for muscle and joint problems [14]. All three leave the same gap for your care: long-term proof in people is missing.